Recruiting
Phase 1

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Sponsor:

SFA Therapeutics

Code:

NCT05642182

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SFA002

SFA002

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information